Candela Corp. won clearance from China’s State Food & Drug Administration to bring two of its laser skin treatment devices to market in the People’s Republic.
Wayland, Mass.-based Candela, now a subsidiary of Syneron (NSDQ:ELOS), said the SFDA approved its Alex TriVantage and the GentleMax devices for sale in China and Hong Kong. Syneron CEO Louis Scafuri said the Chinese approvals open up the world’s largest market for cosmetic procedures.
Yokneam, Israel-based Syneron closed its $65 million acquisition of Candela Jan. 5, leaving its shareholders owning 80 percent of the company and former Candela owners with a 20 percent stake.